No. NAD⁺ is not a peptide, and the fact that you had to ask is the fault of the people selling it.
A peptide is a short chain of amino acids joined by peptide bonds — that is the entire definition, and it is what BPC-157, sermorelin and semaglutide are. NAD⁺ is nicotinamide adenine dinucleotide: two nucleotides, nicotinamide mononucleotide and adenosine monophosphate, joined through phosphate groups. It contains no amino acids and no peptide bonds. Different class of molecule entirely.
Why so many sites get it wrong
Two reasons, and the second one matters more.
The first is that NAD⁺ is usually sold from the same shelf as actual peptides. Telehealth providers and compounding pharmacies list NAD⁺ alongside sermorelin, ipamorelin and BPC-157 under a heading like “peptide therapy”, and the category label gets attached to everything under it — which is how it ends up on the injection menus we rank.
The second is that “peptide” has become a marketing word. It signals cutting-edge, prescription-grade, biohacker-adjacent — so it gets applied to products it does not describe. One of the NAD⁺ providers we review calls it “the fountain of youth peptide” on a page that also claims the product is scientifically proven. Both statements are wrong, and they are wrong in the same direction.
Does the distinction actually matter to a buyer?
For your body, not much on its own — NAD⁺ does what it does regardless of what the label calls it. For your judgment of a seller, quite a lot.
A company that misclassifies its own product is telling you something about how carefully the rest of its page was written. When the same page also says “scientifically proven” about outcomes no controlled trial has demonstrated, the pattern is not a typo. It is a habit, and it is worth pricing in.
There is also a practical consequence. Because NAD⁺ gets filed under peptide therapy, people looking for it end up reading peptide research — and the evidence bases are not interchangeable. What is known about NAD⁺ specifically is narrow: oral precursors reliably raise blood NAD⁺ in randomized human trials — in one dose-ranging trial of 80 adults (n = 80), at every dose against placebo and baseline (all p ≤ 0.001) [1] — while the anti-aging outcomes it is marketed for remain unestablished in any format.
So what is NAD⁺, in one sentence?
A coenzyme your cells already use to move electrons through energy metabolism and to fuel DNA-repair enzymes, whose levels fall with age, and which can be raised by taking a precursor — with the caveat that raising it has not been shown to produce the benefits it is sold for.
If you want that unpacked properly, start with our explainer. If you want to know which of the two common precursors has better data, that is NMN vs NR. And if a seller tells you NAD⁺ is a peptide, read the rest of their page with that in mind.